Chapter title |
Statins: Beneficial Effects in Treatment of COVID-19.
|
---|---|
Chapter number | 25 |
Book title |
Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19
|
Published in |
Advances in experimental medicine and biology, June 2023
|
DOI | 10.1007/978-3-031-28012-2_25 |
Pubmed ID | |
Book ISBNs |
978-3-03-128011-5, 978-3-03-128012-2
|
Authors |
Lashgari, Naser-Aldin, Roudsari, Nazanin Momeni, Shamsnia, Hedieh, Shayan, Maryam, Momtaz, Saeideh, Abdolghaffari, Amir Hossein, Matbou Riahi, Maryam, Jamialahmadi, Tannaz, Guest, Paul C, Reiner, Željko, Sahebkar, Amirhossein, Guest, Paul C. |
Abstract |
The recent viral disease COVID-19 has attracted much attention. The disease is caused by SARS-CoV-19 virus which has different variants and mutations. The mortality rate of SARS-CoV-19 is high and efforts to establish proper therapeutic solutions are still ongoing. Inflammation plays a substantial part in the pathogenesis of this disease causing mainly lung tissue destruction and eventually death. Therefore, anti-inflammatory drugs or treatments that can inhibit inflammation are important options. Various inflammatory pathways such as nuclear factor Kappa B (NF-κB), signal transducer of activators of transcription (STAT), nod-like receptor family protein 3 (NLRP), toll-like receptors (TLRs), mitogen-activated protein kinase (MAPK), and mammalian target of rapamycin (mTOR) pathways and mediators, such as interleukin (IL)-6, IL-1β, tumor necrosis factor-α (TNF-α), and interferon-γ (INF-γ), cause cell apoptosis, reduce respiratory capacity and oxygen supply, eventually inducing respiratory system failure and death. Statins are well known for controlling hypercholesterolemia and may serve to treat COVID-19 due to their pleiotropic effects among which are anti-inflammatory in nature. In this chapter, the anti-inflammatory effects of statins and their possible beneficial effects in COVID-19 treatment are discussed. Data were collected from experimental and clinical studies in English (1998-October 2022) from Google Scholar, PubMed, Scopus, and the Cochrane Library. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 2 | 40% |
Librarian | 1 | 20% |
Researcher | 1 | 20% |
Unknown | 1 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Veterinary Science and Veterinary Medicine | 1 | 20% |
Biochemistry, Genetics and Molecular Biology | 1 | 20% |
Immunology and Microbiology | 1 | 20% |
Engineering | 1 | 20% |
Unknown | 1 | 20% |